Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
2.740
+0.040 (1.48%)
At close: May 18, 2026, 4:00 PM EDT
2.770
+0.030 (1.09%)
After-hours: May 18, 2026, 7:16 PM EDT
Evotec SE Employees
Evotec SE had 4,467 employees as of December 31, 2025. The number of employees decreased by 273 or -5.76% compared to the previous year.
Employees
4,467
Change
-273
Growth
-5.76%
Revenue / Employee
$192,306
Profits / Employee
-$50,042
Market Cap
974.39M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4,467 | -273 | -5.76% |
| Sep 30, 2025 | 4,788 | -219 | -4.37% |
| Jun 30, 2025 | 4,759 | -263 | -5.24% |
| Mar 31, 2025 | 4,766 | -289 | -5.72% |
| Dec 31, 2024 | 4,740 | -321 | -6.34% |
| Sep 30, 2024 | 5,007 | -79 | -1.55% |
| Jun 30, 2024 | 5,022 | -45 | -0.89% |
| Mar 31, 2024 | 5,055 | 103 | 2.08% |
| Dec 31, 2023 | 5,061 | 109 | 2.20% |
| Sep 30, 2023 | 5,086 | 371 | 7.87% |
| Jun 30, 2023 | 5,067 | 546 | 12.08% |
| Dec 31, 2022 | 4,952 | 754 | 17.96% |
| Sep 30, 2022 | 4,715 | 634 | 15.54% |
| Jun 30, 2022 | 4,521 | 607 | 15.51% |
| Mar 31, 2022 | 4,354 | 619 | 16.57% |
| Dec 31, 2021 | 4,198 | 626 | 17.53% |
| Sep 30, 2021 | 4,081 | 637 | 18.50% |
| Jun 30, 2021 | 3,914 | 636 | 19.40% |
| Mar 31, 2021 | 3,735 | 705 | 23.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Phibro Animal Health | 2,475 |
| Amphastar Pharmaceuticals | 1,976 |
| Alvotech | 1,279 |
| Pacira BioSciences | 829 |
| Cronos Group | 610 |
| Xeris Biopharma Holdings | 435 |
| Collegium Pharmaceutical | 423 |
| Harrow | 373 |
EVO News
- 6 days ago - Evotec SE (EVO) Issues â¬116.1M Convertible Bonds to Support Project Horizon - GuruFocus
- 6 days ago - Evotec SE Successfully Placed €116.1 Million Convertible Bonds - Accesswire
- 6 days ago - EQS-Adhoc: Evotec SE launches approximately EUR 125 million convertible bond offering - Wallstreet:Online
- 13 days ago - EQS-DD: Evotec SE: Paul Hitchin, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system. - Wallstreet:Online
- 13 days ago - EQS-DD: Evotec SE: Aurélie Dalbiez, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system. - Wallstreet:Online
- 13 days ago - EQS-DD: Evotec SE: Dr. Christian Wojczewski, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system. - Wallstreet:Online
- 13 days ago - EQS-DD: Evotec SE: Dr. Cord Dohrmann, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system. - Wallstreet:Online
- 13 days ago - EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online